Cargando…

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection

BACKGROUND: A reduction in duration of antibiotic therapy is crucial in minimizing the development of antimicrobial resistance, drug-related side effects and health care costs. The minimal effective duration of antimicrobial therapy for febrile urinary tract infections (fUTI) remains a topic of unce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stalenhoef, Janneke Evelyne, van Nieuwkoop, Cees, Wilson, Darius Cameron, van der Starre, Willize Elizabeth, van der Reijden, Tanny J. K., Delfos, Nathalie Manon, Leyten, Eliane Madeleine Sophie, Koster, Ted, Ablij, Hans Christiaan, van ‘t Wout, Johannes (Jan) Willem, van Dissel, Jaap Tamino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376649/ https://www.ncbi.nlm.nih.gov/pubmed/30764769 http://dx.doi.org/10.1186/s12879-019-3789-6

Ejemplares similares

Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule
por: Stalenhoef, Janneke E., et al.
Publicado: (2017)

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women
por: van Nieuwkoop, Cees, et al.
Publicado: (2017)

Diabetes and the Course of Febrile Urinary Tract Infection
por: van der Starre, Willize E., et al.
Publicado: (2013)

Treatment Duration of Febrile Urinary Tract Infections
por: van der Starre, Willize E., et al.
Publicado: (2011)

Urinary Proteins, Vitamin D and Genetic Polymorphisms as Risk Factors for Febrile Urinary Tract Infection and Relation with Bacteremia: A Case Control Study
por: van der Starre, Willize E., et al.
Publicado: (2015)

Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study
por: van Nieuwkoop, Cees, et al.
Publicado: (2010)

Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)
por: van Nieuwkoop, Cees, et al.
Publicado: (2009)

Current Pyuria Cutoffs Promote Inappropriate Urinary Tract Infection Diagnosis in Older Women
por: Bilsen, Manu P, et al.
Publicado: (2023)

Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination
por: Angeletti, Silvia, et al.
Publicado: (2015)

Deimplementation strategy to reduce overtreatment of asymptomatic bacteriuria: a study protocol for a stepped-wedge cluster randomised trial
por: van Horrik, Tessa MZXK, et al.
Publicado: (2021)

Intravesical aminoglycoside instillations as prophylaxis for recurrent urinary tract infection: patient satisfaction, long-term safety and efficacy
por: Bilsen, Manu P, et al.
Publicado: (2023)

The role of procalcitonin in febrile patients
por: Hatipoglu, Mustafa, et al.
Publicado: (2015)

Corona in het hospice: Hospice Kromme Rijnstreek handelt snel en adequaat
por: van der Starre, Anja
Publicado: (2020)

Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections – ‘triple p in uti’: study protocol for a randomized controlled trial
por: Drozdov, Daniel, et al.
Publicado: (2013)

Comprehensive Assessment of Mid-Regional Proadrenomedullin, Procalcitonin, Neuron-Specific Enolase and Protein S100 for Predicting Pediatric Severe Trauma Outcomes
por: Zakirov, Rustam, et al.
Publicado: (2023)

Multidrug-Resistant Acinetobacter baumannii in Veterinary Clinics, Germany
por: Zordan, Sabrina, et al.
Publicado: (2011)

Procalcitonin as a potent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency department
por: Limper, M., et al.
Publicado: (2011)

Does serum procalcitonin have a diagnostic value in febrile adult patients presenting to the emergency department?
por: van Oers, Jos AH, et al.
Publicado: (2007)

Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis
por: Fahmey, Sameh Samir, et al.
Publicado: (2018)

Real-time registration of adverse events in Dutch hospitalized children in general pediatric units: first experiences
por: van der Starre, Cynthia, et al.
Publicado: (2011)

Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial( )
por: ten Doesschate, Thijs, et al.
Publicado: (2021)

Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia
por: Astapovskii, Aleksandr A., et al.
Publicado: (2022)

(1)H NMR-based metabolic profiling of urinary tract infection: combining multiple statistical models and clinical data
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2012)

Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department
por: Piccioni, Andrea, et al.
Publicado: (2021)

Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment.
por: van Crevel, R, et al.
Publicado: (2001)

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)
por: ten Doesschate, Thijs, et al.
Publicado: (2018)

The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients
por: Moustafa, Rania, et al.
Publicado: (2021)

Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study
por: Alcoba, Gabriel, et al.
Publicado: (2015)

MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children
por: Peñalver Penedo, Rafael, et al.
Publicado: (2021)

Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial
por: Groeneveld, Geert H, et al.
Publicado: (2019)

Targeting the GFI1/1B—CoREST Complex in Acute Myeloid Leukemia
por: van Bergen, Maaike G. J. M., et al.
Publicado: (2019)

Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients
por: Neuenschwander, Letícia Carvalho, et al.
Publicado: (2011)

Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
por: Hemming, Victoria, et al.
Publicado: (2017)

Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies
por: Yang, Mina, et al.
Publicado: (2019)

Usefulness of Midregional Proadrenomedullin to Predict Poor Outcome in Patients with Community Acquired Pneumonia
por: Gordo-Remartínez, Susana, et al.
Publicado: (2015)

Mid-Regional Proadrenomedullin as a New Biomarker of Kidney and Cardiovascular Diseases—Is It the Future?
por: Czajkowska, Katarzyna, et al.
Publicado: (2021)

Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022)

The role of proadrenomedullin, interleukin 6 and CD64 in the diagnosis and prognosis of septic shock
por: Turan, Yasemin Bozkurt
Publicado: (2023)

Automated Directional Measurement System for the Acquisition of Thermal Radiative Measurements of Vegetative Canopies
por: Timmermans, Joris, et al.
Publicado: (2009)

Synergism between the Synthetic Antibacterial and Antibiofilm Peptide (SAAP)-148 and Halicin
por: van Gent, Miriam E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_klaef4olkas8pvlbvsqq01ue35